中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2014年
25期
46-46,48
,共2页
轮状病毒肠炎%薄芝糖肽%探讨
輪狀病毒腸炎%薄芝糖肽%探討
륜상병독장염%박지당태%탐토
Rotavirus enteritis%Bozhi glycopeptide%Investigation
目的：探讨薄芝糖肽治疗轮状病毒肠炎的疗效和安全性。方法：收治轮状病毒肠炎患者158例，随机分为治疗组80例和对照组78例，两组均按常规治疗。治疗组在此基础上给予薄芝糖肽静滴。结果：治疗组总有效率95%，对照组总有效率87.2%，差异有统计学意义(P＜0.05)。结论：薄芝糖肽治疗轮状病毒肠炎优于常规治疗，且无明显不良反应。
目的：探討薄芝糖肽治療輪狀病毒腸炎的療效和安全性。方法：收治輪狀病毒腸炎患者158例，隨機分為治療組80例和對照組78例，兩組均按常規治療。治療組在此基礎上給予薄芝糖肽靜滴。結果：治療組總有效率95%，對照組總有效率87.2%，差異有統計學意義(P＜0.05)。結論：薄芝糖肽治療輪狀病毒腸炎優于常規治療，且無明顯不良反應。
목적：탐토박지당태치료륜상병독장염적료효화안전성。방법：수치륜상병독장염환자158례，수궤분위치료조80례화대조조78례，량조균안상규치료。치료조재차기출상급여박지당태정적。결과：치료조총유효솔95%，대조조총유효솔87.2%，차이유통계학의의(P＜0.05)。결론：박지당태치료륜상병독장염우우상규치료，차무명현불량반응。
Objective:To explore the efficacy and safety of Bozhi glycopeptide in the treatment of rotavirus enteritis.Methods:158 cases with rotavirus enteritis were selected.They were randomly divided into the treatment group of 80 cases and the control group of 78 cases.They were treated with conventional therapy.The treatment group were treated with Bozhi glycopeptide intravenously based on this.Results:The total effective rate of the treatment group was 95%.The total efficiency of the control group was 87.2%. The difference was statistically significant(P<0.05).Conclusion:Bozhi glycopeptide in the treatment of rotavirus enteritis is superior to conventional treatment,and there is no obvious adverse reaction.
